These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 28109882)

  • 21. Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.
    Breugelmans JG; Lewis RF; Agbenu E; Veit O; Jackson D; Domingo C; Böthe M; Perea W; Niedrig M; Gessner BD; Yactayo S;
    Vaccine; 2013 Apr; 31(14):1819-29. PubMed ID: 23395587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.
    Wkly Epidemiol Rec; 2013 Jul; 88(27):269-83. PubMed ID: 23909008
    [No Abstract]   [Full Text] [Related]  

  • 23. Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.
    Adrien N; Hyde TB; Gacic-Dobo M; Hombach J; Krishnaswamy A; Lambach P
    Vaccine; 2019 Jul; 37(32):4511-4517. PubMed ID: 31266670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing epidemiology of yellow fever virus in Oyo State, Nigeria.
    Bassey BE; Braka F; Onyibe R; Kolude OO; Oluwadare M; Oluwabukola A; Omotunde O; Iyanda OA; Tella AA; Olanike OS
    BMC Public Health; 2022 Mar; 22(1):467. PubMed ID: 35260123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yellow fever situation in Africa and South America, 2005.
    Wkly Epidemiol Rec; 2006 Aug; 81(33):317-24. PubMed ID: 16924775
    [No Abstract]   [Full Text] [Related]  

  • 26. Modelling the large-scale yellow fever outbreak in Luanda, Angola, and the impact of vaccination.
    Zhao S; Stone L; Gao D; He D
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006158. PubMed ID: 29338001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological monitoring of the last outbreak of yellow fever in Brazil - An outlook from Portugal.
    Selemane I
    Travel Med Infect Dis; 2019; 28():46-51. PubMed ID: 30583006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yellow fever as an endemic/epidemic disease and priorities for vaccination.
    Monath TP
    Bull Soc Pathol Exot; 2006 Dec; 99(5):341-7. PubMed ID: 17253051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease.
    Silva NIO; Sacchetto L; de Rezende IM; Trindade GS; LaBeaud AD; de Thoisy B; Drumond BP
    Virol J; 2020 Jan; 17(1):9. PubMed ID: 31973727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yellow fever: the recurring plague.
    Tomori O
    Crit Rev Clin Lab Sci; 2004; 41(4):391-427. PubMed ID: 15487593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and control of yellow fever virus: Brazilian outbreak January-April, 2018.
    Callender DM
    Glob Public Health; 2019 Mar; 14(3):445-455. PubMed ID: 30122143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow fever vaccination: how much is enough?
    Massad E; Coutinho FA; Burattini MN; Lopez LF; Struchiner CJ
    Vaccine; 2005 Jun; 23(30):3908-14. PubMed ID: 15917112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yellow fever in Africa and South America, 2011–2012.
    Wkly Epidemiol Rec; 2013 Jul; 88(28):285-96. PubMed ID: 23909009
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical evidence for the immunogenicity and immune persistence of vaccination with yellow fever virus strain 17D in Chinese peacekeepers deployed to Africa.
    Jia Q; Jia C; Liu Y; Yang Y; Qi J; Tong L; Chen H; Zhang M; Che J; Li B; Li Z
    Antiviral Res; 2019 Feb; 162():1-4. PubMed ID: 30529359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.
    Mengesha Tsegaye M; Beyene B; Ayele W; Abebe A; Tareke I; Sall A; Yactayo S; Shibeshi ME; Staples E; Belay D; Lilay A; Alemu A; Alemu E; Kume A; H/Mariam A; Ronveaux O; Tefera M; Kassa W; Bekele Weyessa A; Jima D; Kebede A; Tayachew A
    BMC Public Health; 2018 Aug; 18(1):1011. PubMed ID: 30107830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Yellow fever--a tropical danger].
    Stingl P
    MMW Fortschr Med; 2004 Aug; 146(31-32):36-7. PubMed ID: 15529706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yellow fever in the WHO African and American Regions, 2010.
    Wkly Epidemiol Rec; 2011 Aug; 86(34):370-6. PubMed ID: 21853629
    [No Abstract]   [Full Text] [Related]  

  • 38. Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination.
    Kongsgaard M; Bassi MR; Rasmussen M; Skjødt K; Thybo S; Gabriel M; Hansen MB; Christensen JP; Thomsen AR; Buus S; Stryhn A
    Sci Rep; 2017 Apr; 7(1):662. PubMed ID: 28386132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of YF-neutralizing antibodies in vulnerable populations of Brazil: A warning for epidemiological surveillance and the potential risks for future outbreaks.
    Stoffella-Dutra AG; Silva de Oliveira J; Barbosa Costa G; Geessien Kroon E; Santos Abrahão J; Desiree LaBeaud A; Paiva Drumond B; Bretas de Oliveira D; de Souza Trindade G
    Vaccine; 2020 Sep; 38(42):6592-6599. PubMed ID: 32788140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
    Gaythorpe KA; Abbas K; Huber J; Karachaliou A; Thakkar N; Woodruff K; Li X; Echeverria-Londono S; ; Ferrari M; Jackson ML; McCarthy K; Perkins TA; Trotter C; Jit M
    Elife; 2021 Jun; 10():. PubMed ID: 34165077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.